Mohammad Hosseini Akbar, Majidi Jafar, Baradaran Behzad, Yousefi Mehdi
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Adv Pharm Bull. 2015 Dec;5(Suppl 1):605-14. doi: 10.15171/apb.2015.082. Epub 2015 Dec 31.
Human Toll-like receptors (TLRs) are a family of transmembrane receptors, which play a key role in both innate and adaptive immune responses. Beside of recognizing specific molecular patterns that associated with different types of pathogens, TLRs may also detect a number of self-proteins and endogenous nucleic acids. Activating TLRs lead to the heightened expression of various inflammatory genes, which have a protective role against infection. Data rising predominantly from human patients and animal models of autoimmune disease indicate that, inappropriate triggering of TLR pathways by exogenous or endogenous ligands may cause the initiation and/or perpetuation of autoimmune reactions and tissue damage. Given their important role in infectious and non-infectious disease process, TLRs and its signaling pathways emerge as appealing targets for therapeutics. In this review, we demonstrate how TLRs pathways could be involved in autoimmune disorders and their therapeutic application.
人类 Toll 样受体(TLR)是一类跨膜受体家族,在先天性和适应性免疫反应中均发挥关键作用。除了识别与不同类型病原体相关的特定分子模式外,TLR 还可能检测多种自身蛋白和内源性核酸。激活 TLR 会导致各种炎症基因的表达增强,这些基因对感染具有保护作用。主要来自人类患者和自身免疫性疾病动物模型的数据表明,外源性或内源性配体对 TLR 通路的不适当触发可能会导致自身免疫反应和组织损伤的启动和/或持续。鉴于 TLR 在感染性和非感染性疾病过程中的重要作用,TLR 及其信号通路成为有吸引力的治疗靶点。在本综述中,我们阐述了 TLR 通路如何参与自身免疫性疾病及其治疗应用。